S

Sientra Inc
F:S0Z

Watchlist Manager
Sientra Inc
F:S0Z
Watchlist
Price: 1.302 EUR -3.41% Market Closed
Market Cap: €206.4m

Net Margin

-77%
Current
Declining
by 0.5%
vs 3-y average of -76.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-77%
=
Net Income
$-59.1m
/
Revenue
$90.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-77%
=
Net Income
€-59.1m
/
Revenue
$90.3m

Peer Comparison

Country Company Market Cap Net
Margin
US
Sientra Inc
F:S0Z
206.4m EUR
Loading...
JP
Hoya Corp
TSE:7741
8.6T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.4B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.8B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
119.1B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.9B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
KR
HLB Inc
KOSDAQ:028300
8.8T KRW
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF
Loading...

Market Distribution

Lower than 84% of companies in the United States of America
Percentile
16th
Based on 15 072 companies
16th percentile
-77%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Sientra Inc
Glance View

Market Cap
206.4m EUR
Industry
Health Care

Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Santa Barbara, California and currently employs 319 full-time employees. The company went IPO on 2014-10-29. The firm's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. The firm sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The firm also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Platinum20, Sientra Smooth, Sientra Teardrop, Allox, Allox2, Anatomical Controlled, BIOCORNEUM, Curve, Luxe, Softspan, Silishield and AuraG.

S0Z Intrinsic Value
Not Available
S
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-77%
=
Net Income
$-59.1m
/
Revenue
$90.3m
What is Sientra Inc's current Net Margin?

The current Net Margin for Sientra Inc is -77%, which is below its 3-year median of -76.5%.

How has Net Margin changed over time?

Over the last 3 years, Sientra Inc’s Net Margin has increased from -172.9% to -77%. During this period, it reached a low of -223.7% on Mar 31, 2021 and a high of -29.5% on Jun 30, 2022.

Back to Top